Giesinger, JM
Giesinger, JM
Department of Psychiatry and Psychotherapy, Innsbruck Medical University
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
The “forgotten joint” as the ultimate goal in joint arthroplasty: validation of a new patient-reported outcome measure
H Behrend, K Giesinger, JM Giesinger, MS Kuster
The Journal of arthroplasty 27 (3), 430-436. e1, 2012
Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust
JM Giesinger, JM Kieffer, PM Fayers, M Groenvold, MA Petersen, ...
Journal of clinical epidemiology 69, 79-88, 2016
Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?
A Zabernigg, EM Gamper, JM Giesinger, G Rumpold, G Kemmler, ...
The oncologist 15 (8), 913-920, 2010
Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research
JM Giesinger, FLC Loth, NK Aaronson, JI Arraras, G Caocci, F Efficace, ...
Journal of clinical epidemiology 118, 1-8, 2020
Comparative responsiveness of outcome measures for total knee arthroplasty
K Giesinger, DF Hamilton, B Jost, B Holzner, JM Giesinger
Osteoarthritis and cartilage 22 (2), 184-189, 2014
The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring
B Holzner, JM Giesinger, J Pinggera, S Zugal, F Schöpf, ...
BMC medical informatics and decision making 12, 1-11, 2012
Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review
EM Gamper, A Zabernigg, LM Wintner, JM Giesinger, ...
Journal of pain and symptom management 44 (6), 880-895, 2012
WOMAC, EQ-5D and knee society score thresholds for treatment success after total knee arthroplasty
JM Giesinger, DF Hamilton, B Jost, H Behrend, K Giesinger
The Journal of arthroplasty 30 (12), 2154-2158, 2015
Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain
JM Giesinger, W Kuijpers, T Young, KA Tomaszewski, E Friend, ...
Health and Quality of Life Outcomes 14, 1-8, 2016
Clinical performance of all-ceramic inlay and onlay restorations in posterior teeth.
US Beier, I Kapferer, D Burtscher, JM Giesinger, H Dumfahrt
International Journal of Prosthodontics 25 (4), 2012
Age-and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients
S Singer, S Kuhnt, R Zwerenz, K Eckert, D Hofmeister, A Dietz, ...
British journal of cancer 105 (3), 445-451, 2011
Validation of the English language Forgotten Joint Score-12 as an outcome measure for total hip and knee arthroplasty in a British population
DF Hamilton, FL Loth, JM Giesinger, K Giesinger, DJ MacDonald, ...
The bone & joint journal 99 (2), 218-224, 2017
Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation
S Pallua, J Giesinger, A Oberguggenberger, G Kemmler, D Nachbaur, ...
Bone marrow transplantation 45 (10), 1534-1539, 2010
International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer
S Wheelwright, AS Darlington, D Fitzsimmons, P Fayers, JI Arraras, ...
British journal of cancer 109 (4), 852-858, 2013
Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice
A Erharter, J Giesinger, G Kemmler, G Schauer-Maurer, G Stockhammer, ...
Journal of pain and symptom management 39 (2), 219-229, 2010
Quality of life trajectory in patients with advanced cancer during the last year of life
JM Giesinger, LM Wintner, AS Oberguggenberger, EM Gamper, M Fiegl, ...
Journal of palliative medicine 14 (8), 904-912, 2011
Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
EM Gamper, LM Wintner, M Rodrigues, S Buxbaum, B Nilica, S Singer, ...
European journal of nuclear medicine and molecular imaging 42, 1179-1188, 2015
Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
LM Wintner, JM Giesinger, A Zabernigg, M Sztankay, V Meraner, G Pall, ...
British journal of cancer 109 (9), 2301-2308, 2013
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)
A Oberguggenberger, M Hubalek, M Sztankay, V Meraner, B Beer, ...
Breast cancer research and treatment 128, 553-561, 2011
Responsiveness and ceiling effects of the Forgotten Joint Score-12 following total hip arthroplasty
DF Hamilton, JM Giesinger, DJ MacDonald, A Simpson, CR Howie, ...
Bone & joint research 5 (3), 87-91, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20